Țară: Canada
Limbă: engleză
Sursă: Health Canada
ETHACRYNIC ACID (ETHACRYNATE SODIUM)
STERIMAX INC
C03CC01
ETACRYNIC ACID
50MG
POWDER FOR SOLUTION
ETHACRYNIC ACID (ETHACRYNATE SODIUM) 50MG
INTRAVENOUS
1VIAL
Prescription
LOOP DIURETICS
Active ingredient group (AIG) number: 0101703001; AHFS:
APPROVED
2017-11-02
PRODUCT MONOGRAPH Intravenous Pr ETHACRYNATE SODIUM FOR INJECTION USP Lyophilized powder for injection, 50 mg equivalent to ethacrynic acid PHARMACOLOGICAL CLASSIFICATION Saluretic-Diuretic Agent SteriMax Inc. Date of Preparation: 2770 Portland Drive November 1, 2017 Oakville, ON L6H 6R4 Control No. 204211 PRODUCT MONOGRAPH Intravenous Pr ETHACRYNATE SODIUM FOR INJECTION USP Lyophilized powder for injection, 50 mg equivalent to ethacrynic acid PHARMACOLOGICAL CLASSIFICATION Saluretic-Diuretic Agent ACTION AND CLINICAL PHARMACOLOGY Ethacrynic acid is a saluretic-diuretic agent with marked potency and rapid onset of action. It is chemically unrelated to other diuretics. Patients with congestive heart failure (including acute pulmonary edema), renal edema, hepatic cirrhosis with ascites, and other conditions involving fluid retention have responded well to ethacrynic acid. Ethacrynic acid has the following major characteristics: (1) WATER AND ELECTROLYTE EXCRETION may be increased several times over that observed with thiazide diuretics. The urinary output is usually dose-dependent and related to the magnitude of fluid accumulation. (2) ELECTROLYTE EXCRETION PATTERN DIFFERS FROM THAT OF THIAZIDES. Initially, sodium and chloride excretion is usually substantial, and chloride loss exceeds that of sodium. With prolonged therapy, chloride excretion declines, and potassium and hydrogen ion excretion may increase. In patients with increased diuresis excessive amounts of potassium may be excreted. Ethacrynic acid is effective whether or not there is clinical acidosis or alkalosis. (3) RAPID ONSET OF ACTION usually is observed within 5 minutes after an intravenous injection. (4) SULFHYDRYL BINDING PROPENSITY differs in certain respects from that of the organomercurials. Its mode of action is not by carbonic anhydrase inhibition. (5) MULTIPLE SITES OF ACTION. Ethacrynic acid acts on the proximal and distal portions of the tubule, and also on the ascending limb of the loop of Henle. INDICATIONS AND CLINICAL USE Ethacrynate So Citiți documentul complet